EyePoint Pharmaceuticals Inc. buy Citigroup Inc.
Start price
09.03.26
/
50%
€13.50
Target price
09.03.27
€30.36
Performance (%)
-9.60%
Price
08:55
?
Summary
This prediction is currently active. With a performance of -9.60%, the BUY prediction for EyePoint Pharmaceuticals Inc. by Citigroup_Inc_ is down slightly. This prediction currently runs until 09.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| EyePoint Pharmaceuticals Inc. | -1.681% | -1.681% |
| iShares Core DAX® | 0,41 % | 8,82 % |
| iShares Nasdaq 100 | 3,68 % | 10,82 % |
| iShares Nikkei 225® | 2,70 % | 15,25 % |
| iShares S&P 500 | 2,44 % | 7,93 % |
Comments by Citigroup_Inc_ for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its price target raised by Citigroup Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€8.89
07.01.25
07.01.25
€31.74
07.01.26
07.01.26
63.26%
08.01.26
08.01.26
